Menu
Back to Journals » Vascular Health and Risk Management » Volume 14
Original Research
All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,328 | Dovepress* | 5,945+ | 1,174 | 7,119 | |
| PubMed Central* | 383 | 136 | 519 | ||
| Totals | 6,328 | 1,310 | 7,638 | ||
| *Since 20 November 2018 | |||||
View citations on PubMed Central and Google Scholar